Peer-reviewed medical journal Online-first publishing model

Open access scholarly publishing

American Journal of Medical and Clinical Sciences

A clean, publisher-style platform for clinical science, evidence summaries, and online-first research dissemination.

Open Access Peer Reviewed Rapid Online First

Current publishing cycle

Editorial updates

Follow new and recently accepted papers as they move through the journal.

1.387 Impact factor
Open Access model

Article details

Bilateral Foveoschisis Due to a Mutation in CRB1: Clinical, Genetic and Multimodal Characterisation in a Case Report

Barrera-Arshavin Piero, Bayo-Burgos Antonia, Urrejola-Irarrazabal Eduardo, Rivas-Figueroa María José, Cornejo-Ayala Laura, Verdaguer-Diaz Juan Ignacio.

Abstract

Purpose: To detail the clinical, multimodal imaging and genetic findings of a patient with bilateral foveoschisis caused by the in-frame c.498_506del (p.Ile167_Gly169del) variant in CRB1, emphasizing distinctions from other hereditary cystic maculopathies. 

Case Description: A 19-year-old man presented with blurred vision (BCVA 20/40 OD, 20/50 OS). Anterior segment and peripheral retina were unremarkable. High-resolution macular OCT disclosed multilamellar intraretinal cavities and hyper-reflective "pillar" columns centred on the fovea; fundus autofluorescence showed a faint parafoveal hyper autofluorescent halo without vitelliform or fleck deposits. Full-field ERG was normal (b/a ≈ 1.6); Goldmann perimetry and color vision were intact. A 330-gene retinal dystrophy panel identified the heterozygous in-frame deletion c.498_506del in CRB1 and excluded variants in RS1, BEST1 and ABCA4. A localized CRB1-associated cystic maculopathy was diagnosed; semi-annual monitoring and genetic counseling were instituted. 

Conclusions: Hypomorphic CRB1 variants can produce isolated foveoschisis with preserved peripheral function and a normal ERG, clinically mimicking X-linked juvenile retinoschisis. High-resolution OCT combined with molecular confirmation is essential for accurate differential diagnosis, prognostication and potential enrolment in future CRB1 gene-based therapies.